GlassScriptPhysician profile
Joseph George Schupp
NPI 1326071291
$520.92
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicure Pharma INC. | $102.20 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $99.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $93.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $73.86 | 2019 | |
| Pfizer INC. | $71.84 | 2019 | |
| Alnylam Pharmaceuticals INC. | $64.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Schupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.